GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinocelltech Group Ltd (SHSE:688520) » Definitions » EV-to-EBITDA

Sinocelltech Group (SHSE:688520) EV-to-EBITDA : 144.45 (As of Jun. 28, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Sinocelltech Group EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Sinocelltech Group's enterprise value is ¥28,296 Mil. Sinocelltech Group's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was ¥196 Mil. Therefore, Sinocelltech Group's EV-to-EBITDA for today is 144.45.

The historical rank and industry rank for Sinocelltech Group's EV-to-EBITDA or its related term are showing as below:

SHSE:688520' s EV-to-EBITDA Range Over the Past 10 Years
Min: -1099.17   Med: -33.67   Max: 233.93
Current: 144.45

During the past 9 years, the highest EV-to-EBITDA of Sinocelltech Group was 233.93. The lowest was -1099.17. And the median was -33.67.

SHSE:688520's EV-to-EBITDA is ranked worse than
95.22% of 481 companies
in the Biotechnology industry
Industry Median: 8.87 vs SHSE:688520: 144.45

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-06-28), Sinocelltech Group's stock price is ¥58.90. Sinocelltech Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.200. Therefore, Sinocelltech Group's PE Ratio (TTM) for today is 294.50.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Sinocelltech Group EV-to-EBITDA Historical Data

The historical data trend for Sinocelltech Group's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinocelltech Group EV-to-EBITDA Chart

Sinocelltech Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only -29.69 -33.43 -74.85 -155.10 49.23

Sinocelltech Group Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -364.05 -994.15 243.71 49.23 104.96

Competitive Comparison of Sinocelltech Group's EV-to-EBITDA

For the Biotechnology subindustry, Sinocelltech Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinocelltech Group's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sinocelltech Group's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Sinocelltech Group's EV-to-EBITDA falls into.


;
;

Sinocelltech Group EV-to-EBITDA Calculation

Sinocelltech Group's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=28295.549/195.888
=144.45

Sinocelltech Group's current Enterprise Value is ¥28,296 Mil.
Sinocelltech Group's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥196 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinocelltech Group  (SHSE:688520) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Sinocelltech Group's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=58.90/0.200
=294.50

Sinocelltech Group's share price for today is ¥58.90.
Sinocelltech Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.200.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Sinocelltech Group EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Sinocelltech Group's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinocelltech Group Business Description

Traded in Other Exchanges
N/A
Address
Kechuang Seventh Street, Beijing Economic and Technological Development Zone, Room 307, Building 5, Courtyard 31, Beijing, CHN, 100176
Sinocelltech Group Ltd is engaged in development and industrialization of biopharmaceutical products such as monoclonal antibodies, recombinant proteins and vaccines. The company has developed technology platforms in protein expression vectors, cell line development, serum-free medium development, stoichiometrically controlled fed-batch cell culture, process scale-up, and protein purification. Its capacities include stable CHO cell line development, cell banking and certification, serum-free and protein-free culture medium development, fed-batch cell culture process development, optimization, and process scale-up; protein purification development, and large scale production.
Executives
Xie Liang Zhi Director

Sinocelltech Group Headlines

No Headlines